Alpha Tau Medical Ltd - Class A (DRTS) Stock Price

7.12 ▼ -0.56 (-7.29%)
Open: 7.64 Vol: 370.53K Day's range: 7.00 - 7.64 Jan 16, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
DRTS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 7.10▼ 7.09▲ 7.12▼ 7.19▼ 5.81▲
MA10 7.10▼ 7.15▼ 7.28▼ 6.62▲ 4.95▲
MA20 7.11▼ 7.33▼ 7.45▼ 5.83▲ 4.46▲
MA50 7.29▼ 7.26▼ 6.84▲ 4.78▲ 3.54▲
MA100 7.47▼ 6.65▲ 5.94▲ 4.36▲ 3.08▲
MA200 7.29▼ 5.83▲ 5.13▲ 3.65▲ 4.10▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.014▲ -0.045▼ -0.104▼ 0.164▲ 0.279▲
RSI 40.679▼ 39.809▼ 47.270▼ 67.672▲ 80.950▲
STOCH 57.843     14.374▼ 12.329▼ 87.166▲ 90.536▲
WILL %R -44.444     -92.308▼ -93.789▼ -24.522▲ -17.265▲
CCI 14.894     -67.254     -79.456     88.007     219.781▲
Latest Filters Detected On DRTS
BBANDS $DRTS Bollinger Bands Expanding Set Alert
▼ RSI $DRTS RSI(14) Crossed Below 70 Set Alert
CDL $DRTS Evening Star Candlestick Pattern Detected Set Alert
Alpha Tau Medical Ltd - Class A News
Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic ...
Tuesday, January 06, 2026 06:22 AM
Final results from first pancreatic cancer study in Montreal demonstrate 81% disease control rate, or 87% excluding the first two patients - - Immune markers demonstrate immune system preservation not ...
Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT(R) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)
Monday, January 05, 2026 01:00 AM
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The ...
Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference
Thursday, December 18, 2025 01:00 AM
JERUSALEM, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, ...
DRTS historical stock data
date open high low close volume
16/01/26 7.64 7.64 7.00 7.12 370,532
15/01/26 7.58 7.89 7.05 7.68 940,512
14/01/26 6.81 7.89 6.7761 7.50 1,070,411
13/01/26 7.10 7.15 6.45 6.56 651,743
12/01/26 6.93 7.1299 6.53 7.09 679,504
09/01/26 6.40 6.99 6.3898 6.93 606,073
08/01/26 6.01 6.51 5.72 6.41 929,621
07/01/26 5.86 5.98 5.57 5.90 244,790
06/01/26 5.31 5.87 5.20 5.84 348,361
05/01/26 4.94 5.22 4.90 5.22 211,506
Quote Details
52wk Low:2.30
52wk High:7.89
Vol:370.53K
Avg Vol(3m):4.4M
1Y Chng:+101.13%
1M Chng:+75.37%
Add to Watch List
More Information
Index US Composite
Market Cap. 654.83M